Christer Ahlberg new CEO of Sedana Medical AB (publ)
The Board of Directors of Sedana Medical AB (publ) ("Sedana Medical" or "the Company") has appointed Christer Ahlberg as new CEO for the Company and the group. Christer Ahlberg succeeds Mike Ryan, who will focus on board management inside and outside the group. Christer Ahlberg took up his new position on 1 February 2017.
Christer Ahlberg previously held the position of CEO for the Unimedic Group. Christer was the CEO for six years and during that time he developed the company from being a pharmaceutical contract manufacturer into a specialist pharma company, increasing the turnover from 100 MSEK to 600 MSEK a year. Prior to that, he established the Japanese pharmaceutical company Eisai in the Nordic region and the Baltics. In addition, Christer Ahlberg has solid experience in the pharmaceutical industry, having held leading positions in the areas of management, sales, market and market access at AstraZeneca, Meda and Wyeth.
"It is very exciting and I feel honoured to have gained the trust of the board of directors to lead Sedana Medical. I look forward to leading the team towards our vision of making inhalation sedation, with our products AnaConDa and IsoConDa, to a global standard method for sedating mechanically ventilated patients in intensive care units,” says Christer Ahlberg.
“Sedana Medical has been very focused and goal-oriented to pioneer the development of next-generation sedation therapy. We are convinced that Christer Ahlberg is the right person to lead the company to the next phase registering the new products and entering several new markets. We believe that with Christer’s experience Sedana Medical will soon be able to offer the first commercial inhalation sedation solution in intensive care units,” says Thomas Eklund, Chairman of the Board of Directors in Sedana Medical AB.
For more information, please contact:
Christer Ahlberg, CEO, Sedana Medical AB, +46 70 675 33 30, christer.ahlberg@sedanamedical.com
Thomas Eklund, Chairman of the Board, Sedana Medical AB, 070-824 20 25
_________________________
Sedana Medical AB (publ) is a Swedish company that develops, manufactures and sells the medical device AnaConDa. AnaConDa is a medical device for inhalation sedation of mechanically ventilated patients in intensive care units. At the end of 2016, the company initiated a major clinical study to receive market approval in Europe for IsoConDa (isoflurane) for inhalation sedation in intensive care units. The study is expected to end in late 2018. Registration is expected at the end of 2019. Sedana Medical has sales offices in Germany, Spain and France, as well as external distributors in Europe, the Middle East, Canada, Australia and South Korea. The headquarters is based in Danderyd, Sweden and the company has R&D operations in Ireland.
Tags:
